KYMR
Price
$64.82
Change
+$0.51 (+0.79%)
Updated
Nov 19 closing price
Capitalization
4.67B
91 days until earnings call
Intraday BUY SELL Signals
PDSB
Price
$0.75
Change
-$0.04 (-5.06%)
Updated
Nov 19 closing price
Capitalization
41.04M
126 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

KYMR vs PDSB

Header iconKYMR vs PDSB Comparison
Open Charts KYMR vs PDSBBanner chart's image
Kymera Therapeutics
Price$64.82
Change+$0.51 (+0.79%)
Volume$505.14K
Capitalization4.67B
PDS Biotechnology
Price$0.75
Change-$0.04 (-5.06%)
Volume$503.81K
Capitalization41.04M
KYMR vs PDSB Comparison Chart in %
KYMR
Daily Signal:
Gain/Loss:
PDSB
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
KYMR vs. PDSB commentary
Nov 20, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is KYMR is a Hold and PDSB is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 20, 2025
Stock price -- (KYMR: $64.92 vs. PDSB: $0.75)
Brand notoriety: KYMR and PDSB are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: KYMR: 64% vs. PDSB: 59%
Market capitalization -- KYMR: $4.67B vs. PDSB: $41.04M
KYMR [@Biotechnology] is valued at $4.67B. PDSB’s [@Biotechnology] market capitalization is $41.04M. The market cap for tickers in the [@Biotechnology] industry ranges from $106.82B to $0. The average market capitalization across the [@Biotechnology] industry is $2.12B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

KYMR’s FA Score shows that 0 FA rating(s) are green whilePDSB’s FA Score has 1 green FA rating(s).

  • KYMR’s FA Score: 0 green, 5 red.
  • PDSB’s FA Score: 1 green, 4 red.
According to our system of comparison, both KYMR and PDSB are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

KYMR’s TA Score shows that 4 TA indicator(s) are bullish while PDSB’s TA Score has 4 bullish TA indicator(s).

  • KYMR’s TA Score: 4 bullish, 4 bearish.
  • PDSB’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, KYMR is a better buy in the short-term than PDSB.

Price Growth

KYMR (@Biotechnology) experienced а +2.19% price change this week, while PDSB (@Biotechnology) price change was -22.18% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.19%. For the same industry, the average monthly price growth was -5.74%, and the average quarterly price growth was +63.93%.

Reported Earning Dates

KYMR is expected to report earnings on Feb 19, 2026.

PDSB is expected to report earnings on Mar 26, 2026.

Industries' Descriptions

@Biotechnology (-2.19% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
KYMR($4.67B) has a higher market cap than PDSB($41M). KYMR YTD gains are higher at: 61.372 vs. PDSB (-53.988). PDSB has higher annual earnings (EBITDA): -32.36M vs. KYMR (-267.03M). KYMR has more cash in the bank: 665M vs. PDSB (31.9M). PDSB has less debt than KYMR: PDSB (18.5M) vs KYMR (85.7M). KYMR has higher revenues than PDSB: KYMR (44.7M) vs PDSB (0).
KYMRPDSBKYMR / PDSB
Capitalization4.67B41M11,393%
EBITDA-267.03M-32.36M825%
Gain YTD61.372-53.988-114%
P/E RatioN/AN/A-
Revenue44.7M0-
Total Cash665M31.9M2,085%
Total Debt85.7M18.5M463%
FUNDAMENTALS RATINGS
PDSB: Fundamental Ratings
PDSB
OUTLOOK RATING
1..100
81
VALUATION
overvalued / fair valued / undervalued
1..100
33
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
91
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
KYMRPDSB
RSI
ODDS (%)
Bearish Trend 3 days ago
81%
Bullish Trend 6 days ago
80%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
79%
Momentum
ODDS (%)
Bullish Trend 1 day ago
76%
Bearish Trend 1 day ago
90%
MACD
ODDS (%)
Bullish Trend 1 day ago
78%
Bearish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
80%
Bearish Trend 1 day ago
89%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
80%
Bearish Trend 1 day ago
90%
Advances
ODDS (%)
Bullish Trend 1 day ago
84%
Bullish Trend 9 days ago
84%
Declines
ODDS (%)
Bearish Trend 29 days ago
87%
Bearish Trend 3 days ago
89%
BollingerBands
ODDS (%)
Bearish Trend 6 days ago
90%
Bullish Trend 1 day ago
87%
Aroon
ODDS (%)
Bullish Trend 1 day ago
74%
Bearish Trend 1 day ago
83%
View a ticker or compare two or three
Interact to see
Advertisement
KYMR
Daily Signal:
Gain/Loss:
PDSB
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
APDSX37.130.31
+0.84%
Artisan Small Cap Advisor
RMDCX3.330.02
+0.60%
Virtus Silvant Mid-Cap Growth C
FSPSX59.49N/A
N/A
Fidelity International Index
BSGIX15.17N/A
N/A
Baird Small/Mid Cap Growth Institutional
TSRLX79.95N/A
N/A
Touchstone Large Cap Focused R6

KYMR and

Correlation & Price change

A.I.dvisor indicates that over the last year, KYMR has been loosely correlated with NRIX. These tickers have moved in lockstep 64% of the time. This A.I.-generated data suggests there is some statistical probability that if KYMR jumps, then NRIX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KYMR
1D Price
Change %
KYMR100%
+0.95%
NRIX - KYMR
64%
Loosely correlated
+13.09%
VERA - KYMR
61%
Loosely correlated
-1.25%
IDYA - KYMR
54%
Loosely correlated
-1.72%
RGNX - KYMR
54%
Loosely correlated
-2.84%
NUVL - KYMR
54%
Loosely correlated
+2.71%
More

PDSB and

Correlation & Price change

A.I.dvisor indicates that over the last year, PDSB has been loosely correlated with RXRX. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if PDSB jumps, then RXRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PDSB
1D Price
Change %
PDSB100%
-4.93%
RXRX - PDSB
45%
Loosely correlated
-3.12%
RGNX - PDSB
45%
Loosely correlated
-2.84%
AXON - PDSB
43%
Loosely correlated
-0.50%
KYMR - PDSB
42%
Loosely correlated
+0.95%
DYN - PDSB
42%
Loosely correlated
-1.67%
More